Key Highlights
•
A new study shows that adding chemotherapy to a targeted drug significantly improves outcomes for a specific group of lung cancer patients. For patients with advanced lung cancer driven by an EGFR mutation who also have mutations in tumor suppressor genes, combining aumolertinib with carboplatin-pemetrexed chemotherapy extended the time before the cancer worsened by over 3 months compared to the targeted drug alone.
Source →
•
Obesity prevention is a powerful but underused tool for stopping many types of cancer. This viewpoint argues that tackling obesity could prevent a significant number of cancer cases, highlighting a major opportunity for public health strategies beyond traditional medical treatments.
Source →
•
A specific genetic flaw found in about 15% of cancers, including some lung cancers, makes tumors more vulnerable to a new class of drugs called PRMT5 inhibitors. This discovery opens the door for more personalized treatment strategies, where doctors can match patients with this genetic feature to therapies that specifically target their cancer’s weakness.
Source →
•
An AI model designed to predict death risk in trauma patients was made more accurate and fair by including patient demographic information like age and sex. This improved tool can help doctors make better decisions in emergency care and ensure medical resources are allocated more equitably across different patient groups.
Source →
Only for you Upgrade with 50% Off — Coupon: ERWMCWYU
Stay curious. Stay informed — with
Science Briefing.
This is a one time Briefing, Upgrade to continue.
